Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Breast Cancer Research : BCR
|
December 19, 2008
PGRMC1: a new biomarker for the estrogen receptor in breast cancer
Rolf J Craven
Journal of Cellular Biochemistry
|
October 3, 2003
Hpr6.6 protein mediates cell death from oxidative damage in MCF-7 human breast cancer cells
Randal A Hand, Rolf J Craven
Oncoscience
|
January 17, 2015
Pathways driving the endocytosis of mutant and wild-type EGFR in cancer
Kaia K Hampton, Rolf J Craven
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
June 23, 2005
Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors
Gerard Crudden, Ralf Loesel, Rolf J Craven
The Journal of Pharmacology and Experimental Therapeutics
|
October 20, 2005
Hpr6 (heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs
Gerard Crudden, Rachel E Chitti, Rolf J Craven
Surgical Oncology
|
April 12, 2003
A decade of tyrosine kinases: from gene discovery to therapeutics
Rolf J Craven, Harry Lightfoot, William G Cance
Brain Research
|
December 5, 2021
Dependence of glucose transport on autophagy and GAPDH activity
Rolf J Craven, Hilaree N Frazier, Olivier Thibault
The Journal of Biological Chemistry
|
October 24, 2007
Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11/Cyp51
Rolf J Craven, Julia C Mallory, Randal A Hand
Expert Opinion on Drug Metabolism & Toxicology
|
February 2, 2012
S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling
Ikhlas S A Ahmed, Cora Chamberlain, Rolf J Craven
The Journal of Biological Chemistry
|
March 16, 2012
Neutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1
Shakeel U R Mir, Ling Jin, Rolf J Craven
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Breast Cancer Research : BCR
|
December 19, 2008
PGRMC1: a new biomarker for the estrogen receptor in breast cancer
Rolf J Craven
Journal of Cellular Biochemistry
|
October 3, 2003
Hpr6.6 protein mediates cell death from oxidative damage in MCF-7 human breast cancer cells
Randal A Hand, Rolf J Craven
Oncoscience
|
January 17, 2015
Pathways driving the endocytosis of mutant and wild-type EGFR in cancer
Kaia K Hampton, Rolf J Craven
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
June 23, 2005
Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors
Gerard Crudden, Ralf Loesel, Rolf J Craven
The Journal of Pharmacology and Experimental Therapeutics
|
October 20, 2005
Hpr6 (heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs
Gerard Crudden, Rachel E Chitti, Rolf J Craven
Surgical Oncology
|
April 12, 2003
A decade of tyrosine kinases: from gene discovery to therapeutics
Rolf J Craven, Harry Lightfoot, William G Cance
Brain Research
|
December 5, 2021
Dependence of glucose transport on autophagy and GAPDH activity
Rolf J Craven, Hilaree N Frazier, Olivier Thibault
The Journal of Biological Chemistry
|
October 24, 2007
Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11/Cyp51
Rolf J Craven, Julia C Mallory, Randal A Hand
Expert Opinion on Drug Metabolism & Toxicology
|
February 2, 2012
S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling
Ikhlas S A Ahmed, Cora Chamberlain, Rolf J Craven
The Journal of Biological Chemistry
|
March 16, 2012
Neutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1
Shakeel U R Mir, Ling Jin, Rolf J Craven
Page
of 4